Many laboratories have developed DMD animal models carrying mutations of the dystrophin gene, ranging from invertebrate to large mammalian models, to deepen our understanding of the molecular mechanisms involved in this disorder and to develop biomarkers and therapies for it3. This evidence concerns the gene DMD and Duchenne muscular dystrophy.